Eagle Health Investments LP
Eagle Health Investments LP reported 27 holdings worth US$603M as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 10, 2026
Eagle Health Investments LP reported 27 holdings worth US$603M as of Jun 30, 2026. Largest: Argenx Se, Guardant Health, Inc. and Insmed Incorporated. Filed Aug 10, 2026 (Form 13F).
- Holdings
- 27
- Value as reported
- US$603M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Argenx Se | 76,417 | US$70.9M | 11.8% |
| Guardant Health, Inc. | 301K | US$45.1M | 7.5% |
| Insmed Incorporated | 384K | US$41M | 6.8% |
| Biomarin Pharmaceutical Inc. | 625K | US$35.7M | 5.9% |
| Illumina, Inc. | 187K | US$33M | 5.5% |
| Scholar Rock Holding Corporation | 555K | US$30.5M | 5.1% |
| Protagonist Therapeutics, Inc. | 248K | US$30.4M | 5.0% |
| Ultragenyx Pharmaceutical Inc. | 884K | US$29.5M | 4.9% |
| Revolution Medicines, Inc. | 120K | US$22.5M | 3.7% |
| Fortrea Holdings Inc. | 1.18M | US$20.6M | 3.4% |
| Kymera Therapeutics, Inc. | 166K | US$19.1M | 3.2% |
| Axsome Therapeutics, Inc. | 65,051 | US$15.9M | 2.6% |
| Boston Scientific Corporation | 369K | US$15.8M | 2.6% |
| Ionis Pharmaceuticals, Inc. | 195K | US$15.4M | 2.6% |
| Tempus Ai, Inc. | 256K | US$14.8M | 2.5% |
| Dianthus Therapeutics, Inc. | 131K | US$12.8M | 2.1% |
| Ataibeckley Inc. | 1.71M | US$9.01M | 1.5% |
| Avalo Therapeutics, Inc. | 235K | US$4.34M | 0.72% |
| Natera, Inc. | 15,847 | US$4.3M | 0.71% |
| Eli Lilly And Company | 1,994 | US$2.39M | 0.40% |
| Intuitive Surgical, Inc. | 4,390 | US$1.75M | 0.29% |
| Perceptive Capital Solutions Corp | 37,686 | US$410K | 0.07% |
| Ascendis Pharma A/s | 0 | US$0 | 0.00% |
| Bridgebio Pharma, Inc. | 0 | US$0 | 0.00% |
| Procept Biorobotics Corporation | 0 | US$0 | 0.00% |
| Terns Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
Source
View original at SEC
Related